MASLD | SyncSci Publishing

This website uses cookies to ensure you get the best experience on our website. Learn more

A Review on Resmetirom: An Oral Thyroid Hormone Receptor-β Agonist for the Treatment of Metabolically dysfunction-Associated Steatohepatitis (MASH)

July 13, 2026 Chemistry, Medicine & Health

Authors: Sakshi Mahalpure, Gaurav Sanjay Mahalpure, Vandana Daga, et al.
Journal: Journal of Pharmaceutical and Biopharmaceutical Research
DOI: 10.25082/JPBR.2026.01.002
Pub. Date: July 13, 2026